Abstract
This article deals with a new class of nitric oxide donors—safe medications for the treatment of socially significant diseases. This complex work has been performed in collaboration with a number of RAS institutes, the Russian Cardiology Research and Production Complex, and the Blokhin Russian Cancer Research Center.
Similar content being viewed by others
References
R. Morphy, C. Kay, and Z. Rankovic, “From magic bullets to designed multiple ligands,” Drug Discov. Today 9 (15), 641 (2004).
K. Szacilowski, A. Chmura, and Z. Stasicka, “Interplay between iron complexes, nitric oxide and sulfur ligands: Structure, (photo)reactivity and biological importance,” Coord. Chem. Rev. 249, 2408 (2005).
S. Mocellin, V. Bronte, and D. Nitti, “Nitric oxide, a double edged sword in cancer biology: Searching for therapeutic opportunities,” Med. Res. Rev. 27 (3), 317 (2007).
C. M. Aldoshin and N. A. Sanina, “Functional nitrosyl iron complexes: A new class of nitrogen monoxide donors to cure socially significant diseases,” in Basic Sciences for Medicine: Biophysical Medical Technologies, Ed. by A. I. Grigor’ev and Yu. A. Vladimirov (MAKS-Press, Moscow, 2015), Vol. 1 [in Russian].
J. H. Enemark and R. D. Feltham, “Principles of structure, bonding, and reactivity for metal nitrosyl complexes,” Coord. Chem. Rev. 13 (4), 339 (1974).
S. M. Aldoshin, K. A. Lysenko, M. Yu. Antipin, et al., “Precision X-ray study of mononuclear dinitrosyl iron complex [Fe(SC2H3N3)(SC2H2N3)(NO)2] · 0.5H2O at low temperatures,” J. Mol. Struct. 875, 309 (2008).
A. F. Shestakov, Yu. M. Shul’ga, N. S. Emel’yanova, et al., “Experimental and theoretical study of the arrangement, electronic structure and properties of neutral paramagnetic binuclear nitrosyl iron complexes with azaheterocyclic thyolyls having ‘S–C–N type’ coordination of bridging ligands,” Inorg. Chim. Acta 362, 2499 (2009).
N. Emel’yanova, N. Shmatko, N. Sanina, and S. Aldoshin, “Quantum-chemical study of the Fe(NO)2 fragment in the cation of mononuclear nitrosyl iron complex [Fe(SC(NH2)2)2(NO)2]-l · H2O,” Comput. Theor. Chem. 1060, 1 (2015).
N. A. Sanina and S. M. Aldoshin, “Synthesis, structure, and properties of nitrosyl [2Fe-2S], [1Fe-2S] protein models and their perspective use in biology and medicine,” Ross. Khim. Zh., No. 4, 12 (2004).
N. S. Emel’yanova, N. Yu. Shmatko, N. A. Sanina, et al., “Experimental and quantum-chemical simulation of pH-medium effects on the NO-donor activity of mononuclear nitrosyl iron complex [Fe(SC(NH2)2)2(NO)2]-l · H2O,” Izv. Akad. Nauk. Ser. Khim., No. 10, 2344 (2015).
N. S. Emel’yanova, N. A. Sanina, E. V. Knyaz’kina, et al., “Quantum-chemical simulation of the ‘µ-SCN’type ligand’s effect on the redox properties of nitrosyl iron complexes,” Izv. Akad. Nauk. Ser. Khim., No. 6, 1265 (2014).
N.A.Sanina, L.I.Serebryakova, V.S.Shul’zhenko, et al., RF Patent No. 2437667 (2011).
N.A.Sanina, L.I.Serebryakova, V.S.Shul’zhenko, et al., RF Patent No. 2460531 (2012).
A. Yu. Gosteev, A. V. Zorin, O. V. Rodnenkov, et al., “Hemodynamic effects of the synthetic analog of endogenous nitrogen oxide (II) donators: A dinitrosyl iron complexes preparation in hypertension patients with intact hypertensic crises,” Ter. Arkh., No. 9, 49 (2014).
S. V. Vasil’eva, E. Yu. Moshkovskaya, N. A. Sanina, et al., “Genetic signal transduction by nitrosyl-iron complexes in Escherichia coli,” Biochemistry 69 (8), 883 (2004).
S. V. Vasilieva, E. Ju. Moschkovskaya, A. S. Terekhov, et al., “Intracellular iron ions regulate the genetic activity of NO-donating agents,” Russ. J. Genetics 42 (7), 737 (2006).
O. S. Zhukova, N. A. Sanina, L. V. Fetisova, and G. K. Gerasimova, “Cytotoxic effect of nitrosyl iron complexes on human tumor cells in vitro,” Ross. Bioter. Zh. 5 (1), 14 (2006).
N.A.Sanina, O.S.Zhukova, S.M.Aldoshin, et al., RF Patent No. 2429242 (2011).
N.A.Sanina, O.S.Zhukova, Z.S.Smirnova, et al., RF Patent No. 2441872 (2012).
N.A.Sanina, K.A.Lysenko, O.S.Zhukova, et al., RF Patent No. 2441873 (2012).
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © S.M. Aldoshin, N.A. Sanina, M.I. Davydov, E.I. Chazov, 2016, published in Vestnik Rossiiskoi Akademii Nauk, 2016, Vol. 86, No. 6, pp. 495–500.
RAS Academician Sergei Mikhailovich Aldoshin is director of the RAS Institute of Problems of Chemical Physics (RAS IPCP). Nataliya Alekseevna Sanina, Dr. Sci. (Chem.), is head of the Department of the Structure of Matter, RAS IPCP. RAS Academician Mikhail Ivanovich Davydov is director of the Blokhin Russian Cancer Research Center. RAS Academician Evgenii Ivanovich Chazov is director for science of the Russian Cardiology Research and Production Complex of the Ministry of Health of the Russian Federation.
Rights and permissions
About this article
Cite this article
Aldoshin, S.M., Sanina, N.A., Davydov, M.I. et al. A new class of nitric oxide donors. Her. Russ. Acad. Sci. 86, 158–163 (2016). https://doi.org/10.1134/S1019331616030096
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1019331616030096